Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular The...
Protara Therapeutics, Inc. (TARA)
Company Research
Source: Yahoo! Finance
The market size of vascular malformations is expected to increase during the forecast period (2024–2034) with the increasing prevalence, disease awareness, and entry of promising emerging treatment options. LAS VEGAS June 26, 2024 /PRNewswire/ -- DelveInsight's Vascular Malformations Market Insights report includes a comprehensive understanding of current treatment practices, vascular malformations emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan ]. Key Takeaways from the Vascular Malformations Market Report According to DelveInsight's analysis, the market size for vascular malformations is expected to grow significantly by 2034. As per DelveIsight assessment, of Vascular Malformations cases are found in the 25–44 age group, while 40% and 51% of diabetes cases are found in 25–44 and 45–60 aged in
Show less
Read more
Impact Snapshot
Event Time:
TARA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARA alerts
High impacting Protara Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TARA
News
- Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- ASTS, CRBU and DOMO are among after hour movers [Seeking Alpha]Seeking Alpha
- Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation SummitGlobeNewswire
- UK NICE backs Exact's Oncotype cancer genomic test Fri, May 10, 2024, 3:22 PM GMT+2 2 min read 0 In this article: Advertisement Up next These 2 ‘Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer Thu, May 9, 2024, 7:20 PM GMT+2 6 min read Acquire Media Monitor
TARA
Earnings
- 5/2/24 - Beat
TARA
Sec Filings
- 6/28/24 - Form 4
- 6/27/24 - Form 4
- 6/10/24 - Form 4
- TARA's page on the SEC website